Home> News>Company News

Tongnan District Party Committee leaders visits and inspects Hemony Pharmaceutical Co., Ltd.


On November 22, Shen Rong, member of the Standing Committee of Tongnan District Party Committee and director of the United Front Work Department, and Xiang Ming, vice chairman of Tongnan CPPCC and chairman of the Federation of Industry and Commerce, were invited to visit and inspect Hemony Pharmaceutical Co., Ltd., accompanied by a delegation of businessmen from the Chamber of Commerce in Tongnan District.


Accompanied by Tang Zhichun, Deputy General Manager for Production of Hemony, the visiting leaders and delegation visited Hemony's Science Park and Hemony Pharmaceutical Co., Ltd.'s headquarters in Chongqing. Tang Zhichun introduced the enterprise management and product system planning. During the visit, Shen Rong said that Hemony Pharmaceutical Co., Ltd. had entered a period of rapid development and had great development potential.



After the visit, the two sides held a discussion and exchange in the conference room of Hemony Pharmaceutical Co., Ltd. Jian Min, director of the Public Affairs Department of Hemony Pharmaceutical Co., Ltd., gave a brief introduction to the development process, current management situation and strategic deployment of the enterprise. She said that, since its establishment for more than 10 years ago, the Hemony Pharmaceutical Co., Ltd. had gradually developed into a comprehensive pharmaceutical enterprise integrated with research and development, production, sales and professional promotion, winning widespread praise from doctors and patients and all sectors of society, and expressing gratitude to the leaders at all levels for their attention to Hemony on behalf of the enterprise.


Shen Rong said that the development experience of Hemony Pharmaceutical Co., Ltd. was worth learning from by pharmaceutical enterprises in Tongnan. Tongnan District Government was also willing to build a platform for excellent pharmaceutical enterprises, share resources, unite efforts, promote the co-construction of pharmaceutical brands, and promote the integration and symbiosis of pharmaceutical industries and healthy development. She also said she hoped to take this opportunity to establish contacts, strengthen exchanges and cooperation, and promote integrative development and all-win situation.